Baylor College of Medicine's Arthur Beaudet says he is seeing how genomic testing and sequencing is beginning to have an impact on how physicians approach treating rare disorders.

Beaudet, who has been treating children with rare disorders for 40 years, told MedScape at the recent Future of Genomic Medicine Conference that genetic testing began having an impact on his field through newborn screening. GlobalGenes.org has posted the interview on its site.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Nature this week: mouse genome functional analysis, more sensitive chromatin immunoprecipitation, and more.

The Center for Data Innovation and HealthITNow argue for re-building of genomic research infrastructure.

A Senate committee has unanimously approved a bill to require articles resulting from federally funded projects to be made publicly available, according to ScienceInsider.

The US is heading toward another budget showdown, Nature News says.